ICA-GBS

• Research type

  Research Study

• Full title

  Inhibition of complement activation (eculizumab®) in Guillain-Barré Syndrome study

• IRAS ID

  134339

• Contact name

  Hugh Willison

• Contact email

  hugh.willison@glasgow.ac.uk

• Sponsor organisation

  NHS Greater Glasgow and Clyde, Research and Development

• Eudract number

  2013-000228-33

• REC name

  Scotland A REC

• REC reference

  13/SS/0117

• Date of REC Opinion

  12 Aug 2013

• REC opinion

  Favourable Opinion